Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL04
- Pharmacological subgroupL04A
- Chemical subgroupL04AJ
- Chemical substanceL04AJ04Sutimlimab
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 1 registration
European Union
EMA · 1 registration
Croatia
HALMED · 1 registration
Netherlands
CBG-MEB · 1 registration
United States
FDA · 1 registration
At a glance
- ATC code
- L04AJ04
- Registers
- 5
- Registrations
- 5
- With their own page
- 5
- Companies
- 4
All medicines with Sutimlimab
Human medicines from every register that match Sutimlimab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
5 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Enjaymo | United States | 1,100MG/22ML | injectable | Marketed | Recordati Rare Diseases, INC. |
| Enjaymo | European Union | Authorised | Recordati Rare Diseases | ||
| Enjaymo 50 MG/ML Solucion Para Perfusion | Spain | 50 mg/ml | solución para perfusión | Authorised | Recordati Rare Diseases |
| Enjaymo 50mg/ml, oplossing voor infusie | Netherlands | Oplossing voor infusie | Authorised | Recordati Rare Diseases | |
| Enjaymo | Croatia | Marketed |